Immune to Cancer: The CRI Blog
-
Dr. Ana Aparicio Answers Questions About Prostate Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Ana Aparicio, of The University of Texas MD Anderson Cancer Center, answers questions about prostate cancer…
-
Dr. Nabil F. Saba Answers Questions About Head and Neck Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Nabil F. Saba, of Winship Cancer Institute at Emory University, answers questions about immunotherapy for head…
-
Dr. Van Morris Answers Questions About Colorectal Cancer and Immunotherapy at the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Van Morris, of MD Anderson Cancer Center, answers questions about immunotherapy clinical trials from the 2021…
-
Dr. Hearn Jay Cho Answers Questions About Blood Cancer And Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Hearn Jay Cho, of Mount Sinai Tisch Cancer Institute, answers questions about blood cancer and immunotherapy…
-
Dr. Kunle Odunsi Answers Questions About Immunotherapy Clinical Trials After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical…
-
Dr. Ellen Puré Answers Questions About The Basics of Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Ellen Puré, of the University of Pennsylvania, answers questions about the basics of immunotherapy after the…
-
Acute Lymphoblastic Leukemia Survivor Kristin Kleinhofer Takes Over CRI’s Instagram
Patient advocate and leukemia survivor Kristin shares a day in her life on Instagram.
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
Dr. Terence Friedlander Answers Questions on Bladder Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Terence Friedlander, MD, answers questions about immunotherapy for bladder cancer from the 2020 CRI Virtual Immunotherapy Patient…